Madame Fabienne MARCELLIN / Docteur

Production scientifique

• Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial).
  PLoS One, 2013
  Ndziessi G, Cohen J, Kouanfack C, Marcellin F, Carierri MP, Laborde-Balen G, Protopopescu C, Aghokeng AF, Moatti JP, Spire B, Delaporte E, Laurent C, Boyer S; Stratall ANRS 12110/ESTHER Study Group.
  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640048/
  
• Changes in sexual activity and risk behaviors among PLWHA initiating ART in rural district hospitals in Cameroon -- data from the STRATALL ANRS 12110/ESTHER trial.
  AIDS Care, 2013
  Ndziessi G, Cohen J, Kouanfack C, Boyer S, Moatti JP, Marcellin F, Laurent C, Spire B, Delaporte E, Carrieri MP; ANRS 12110/ESTHER Study Group.
  
  
• Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods.
  Expert Rev Anti Infect Ther., 2013
  Marcellin F, Spire B, Carrieri MP, Roux P.
  
  
• Self-reported alcohol abuse in HIV-HCV co-infected patients: a better predictor of HIV virological rebound than physician's perceptions (HEPAVIH ARNS CO13 cohort).
  Addiction, 2013
  Marcellin F, Lions C, Winnock M, Salmon D, Durant J, Spire B, Mora M, Loko MA, Dabis F, Dominguez S, Roux P, Carrieri MP; ANRS CO13 HEPAVIH Study Group.
  
  
• Adherence as a predictor of sexual behaviors in people living with HIV/AIDS during the first year of antiretroviral therapy in rural Cameroon: data from Stratall ANRS 12110/ESTHER trial.
  PLoS One, 2012
  Ndziessi G, Boyer S, Kouanfack C, Cohen J, Marcellin F, Moatti JP, Delaporte E, Spire B, Laurent C, Carrieri MP; Stratall ANRS 12110/ESTHER Study Group.
  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0036118
  
• Choice of therapeutic strategies in the context of HIV infection: key role of patient-reported outcomes.
  Expert Rev Anti Infect Ther., 2012
  Marcellin F, Carrieri MP, Spire B.
  http://www.expert-reviews.com/doi/abs/10.1586/eri.12.27?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
  
• Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
  AIDS Care, 2012
  Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B; Anrs Co8 Aproco-Copilote Study Group.
  
  
• Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods.
  J Acquir Immune Defic Syndr., 2011
  Roux P, Kouanfack C, Cohen J, Marcellin F, Boyer S, Delaporte E, Carrieri P, Laurent C, Spire B; Stratall ANRS 12110/ESTHER Study Group.
  
  
• Individual and structural factors associated with HIV status disclosure to main partner in Cameroon: ANRS 12-116 EVAL survey, 2006-2007.
  J Acquir Immune Defic Syndr, 2011
  Suzan-Monti M, Blanche J, Bilé P, Koulla-Shiro S, Abu-Zaineh M, Marcellin F, Boyer S, Carrieri MP, Spire B.
  
  
• Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon.
  Health Policy Plan, 2012
  Boyer S, Protopopescu C, Marcellin F, Carrieri MP, Koulla-Shiro S, Moatti JP, Spire B; EVAL Study Group.
  
  
• Reduced delays in time to first HIV consultation after diagnosis in France in the antiretroviral therapy era: the possible role of a free care system.
  HIV Med, 2011
  Suzan-Monti M, Fugon L, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B; VESPA study group.
  
  
• Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV care.
  Antivir Ther, 2011
  Rasson S, Boyer S, Fugon L, Protopopescu C, Marcellin F, Koulla-Shiro S, Kouanfack C, Spire B, Moatti JP, Carrieri MP; EVAL Study Group.
  
  
• Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.
  Soc Sci Med, 2011
  Boyer S, Clerc I, Bonono CR, Marcellin F, Bilé PC, Ventelou B.
  
  
• Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment.
  AIDS Care, 2011
  Marcellin F, Lacombe K, Fugon L, Molina JM, Bonnard P, Miailhes P, Lascoux-Combe C, Roux P, Carrieri MP, Girard PM, Spire B.
  
  
• Psychosocial correlates of inconsistent condom use among HIV-infected patients enrolled in a structured ART interruptions trial in Côte d'Ivoire: results from the TRIVACAN trial (ANRS 1269).
  Trop Med Int Health, 2010
  Protopopescu C, Marcellin F, Préau M, Gabillard D, Moh R, Minga A, Anzian A, Carrieri MP, Danel C, Spire B.
  
  
• Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
  AIDS Care, 2010
  Marcellin F, Protopopescu C, Abé C, Boyer S, Blanche J, Ongolo-Zogo P, Koulla-Shiro S, Moatti JP, Carrieri MP, Spire B; EVAL Study Group.
  
  
• Higher risk of unsafe sex and impaired quality of life among patients not receiving antiretroviral therapy in Cameroon: results from the EVAL survey (ANRS 12-116).
  AIDS, 2010
  Marcellin F, Bonono CR, Blanche J, Carrieri MP, Spire B, Koulla-Shiro S; EVAL Study Group.
  
  
• Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey).
  Sex Transm Infect, 2010
  Dia A, Marcellin F, Bonono RC, Boyer S, Bouhnik AD, Protopopescu C, Koulla-Shiro S, Carrieri MP, Abé C, Spire B; EVAL Study Group.
  
  
• Effect of anxiety symptoms on adherence to highly active antiretroviral therapy in HIV-infected women.
  J Clin Psychiatry, 2009
  Roux P, Carrieri MP, Michel L, Fugon L, Marcellin F, Obadia Y, Spire B.
  
  
• Factors associated with unprotected anal intercourse among men who have sex with men in Douala, Cameroon.
  Sex Transm Infect, 2010
  Henry E, Marcellin F, Yomb Y, Fugon L, Nemande S, Gueboguo C, Larmarange J, Trenado E, Eboko F, Spire B.
  
  
• Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey.
  Bull World Health Organ, 2009
  Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, Moatti JP
  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672585/
  
• Delayed first consultation after diagnosis of HIV infection in Cameroon.
  AIDS, 2009
  Marcellin F, Abé C, Loubière S, Boyer S, Blanche J, Koulla-Shiro S, Ongolo-Zogo P, Moatti JP, Spire B, Carrieri MP; EVAL Study Group.
  
  
• Depressive symptoms and exposure to efavirenz in West African HIV-infected adults.
  HIV Clin Trials, 2008
  Marcellin F, Moh R, Carrieri MP, Danel C, Protopopescu C, Gabillard D, Spire B, Anglaret X.
  
  
• Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116).
  Trop Med Int Health, 2008
  Marcellin F, Boyer S, Protopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, Abega SC, Abé C, Moatti JP, Spire B, Carrieri MP; EVAL Study Group.
  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2008.02170.x/abstract
  
• Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France.
  Addict Behav, 2008
  Roux P, Villes V, Bry D, Spire B, Feroni I, Marcellin F, Carrieri MP.
  
  
• Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
  Antivir Ther, 2008
  Spire B, Marcellin F, Cohen-Codar I, Flandre P, Boue F, Dellamonica P, Raffi F, Norton M, Van Philippe N, Delfraissy JF.
  
  
• Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
  J Clin Gastroenterol, 2008
  Préau M, Marcellin F, Spire B, Ravaux I, Dellamonica P, Blanc D, Carrieri MP.
  
  
• Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research.
  HIV Clin Trials, 2007
  Marcellin F, Préau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP.
  http://thomasland.metapress.com/content/j6515487222286n8/?genre=article&id=doi%3a10.1310%2fhct0805-320
  
• Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study.
  AIDS Res Hum Retroviruses, 2007
  Goujard C, Marcellin F, Hendel-Chavez H, Burgard M, Meiffrédy V, Venet A, Rouzioux C, Taoufik Y, El Habib R, Beumont-Mauviel M, Aboulker JP, Lévy Y, Delfraissy JF; PRIMOVAC-ANRS 095 Study Group.
  
  
• Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects.
  J Pain Symptom Manage, 2007
  Marcellin F, Préau M, Dellamonica P, Ravaux I, Kurkdji P, Protopopescu C, Carrieri MP, Spire B.
  
  
• Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8).
  Qual Life Res, 2007
  Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, Raffi F, Chêne G, Leport C, Carrieri MP.
  
  
• Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study.
  AIDS, 2007
  Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B; VESPA Study Group.
  
  
• Do migrants overreport adherence to highly active antiretroviral therapy?: results from the French VESPA (ANRS-EN12) National Survey.
  J Acquir Immune Defic Syndr, 2006
  Marcellin F, Carrieri MP, Peretti-Watel P, Bouhnik AD, Obadia Y, Lert F, Spire B; VESPA Study Group.
  
  
• Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy.
  AIDS, 2005
  Verstuyft C, Marcellin F, Morand-Joubert L, Launay O, Brendel K, Mentré F, Peytavin G, Gérard L, Becquemont L, Aboulker JP; ANRS081 Study Group.
  
  
• Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy: a randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081).
  J Acquir Immune Defic Syndr, 2005
  Morand-Joubert L, Marcellin F, Launay O, Guiramand-Hugon S, Gérard L, Yeni P, Aboulker JP; Agence Nationale de Recherches sur le SIDA 081 Study Group.
  
  
• CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.
  Clin Exp Immunol, 2001
  Scott-Algara D, Aboulker JP, Durier C, Badell E, Marcellin F, Prud'homme M, Jouanne C, Meiffredy V, Brun-Vezinet F, Pialoux G, Raffi F; ANRS-072 Trial Group.
  http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2249.2001.01680.x/abstract
  
• Addictive behaviors and hepatitis C virus (HCV) clearance following treatment: exploratory study among HIV-HCV co-infected patients (ANRS CO13 HEPAVIH)
  AIDS Care, 0
  MARCELLIN F, COHEN J, SALMON D, WINNOCK M, DABIS F, LOKO MA, GARIPUY D, BOUCHAUD O, SPIRE B, CARRIERI MP, ROUX P for the HEPAVIH (ANRS CO13) Study Group
  
  
• État de santé de la population vivant avec le VIH en France métropolitaine en 2011 et caractéristiques des personnes récemment diagnostiquées. Premiers résultats de l'enquête ANRS-Vespa2
  Bulletin Epidémiologique Hebdomadaire, 2013
  Dray-Spira R, Wilson d'Almeida K, Aubrière C, Marcellin F, Spire B, Lert F et le groupe Vespa2.
  http://www.invs.sante.fr/beh/2013/27/2013_26-27_1.html
  
• . Comportements sexuels des personnes vivant avec le VIH en France en 2011 : premiers résultats de l'enquête ANRS-Vespa2.
  Bulletin Epidémiologique Hebdomadaire, 2013
  Lorente N, Demoulin B, Marcellin F, Dray-Spira R, Spire B et le groupe Vespa2.
  http://www.invs.sante.fr/beh/2013/27/2013_26-27_4.html
  
• La co-infection par le virus de l'hépatite C chez les personnes infectées par le VIH : données de l'enquête ANRS-Vespa2.
  Bulletin Epidémiologique Hebdomadaire, 2013
  Roux P, Demoulin B, Sogni P, Carrieri P, Dray-Spira R, Spire B, Lert F, Marcellin F et le groupe Vespa2.
  http://www.invs.sante.fr/beh/2013/27/2013_26-27_5.html
  
• Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
  Journal of Hepatology, 2014
  Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.
  
  
• Predictors of non-adherence to methadone maintenance treatment in opioid-dependent individuals: implications for clinicians.
  Current Pharmaceutical Design, 2014
  Roux P, Lions C, Michel L, Cohen J, Mora M, Marcellin F, Spire B, Morel A, Carrieri PM, Karila L; ANRS Methaville Study Group.
  
  
• Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial).
  Drug and Alcohol Dependence, 2014
  Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, Spire B, Roux P; Methaville Study Group.
  
  
• Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
  AIDS Care, 2014
  Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, Sagaon-Teyssier L, Lert F, Carrieri MP, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.
  
  
• Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.
  Substance Abuse Treatment & Prevention Policy, 2014
  Roux P, Lions C, Michel L, Mora M, Daulouède JP, Marcellin F, Spire B, Morel A, Carrieri PM; ANRS Methaville study group.
  
  
• Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.
  Expert Review of Gastroenterology & Hepatology, 2014
  Marcellin F, Roux P, Winnock M, Lions C, Dabis F, Salmon-Ceron D, Loko MA, Spire B, Carrieri MP.
  
  
• High Levels of Alcohol Consumption Increase the Risk of Advanced Hepatic Fibrosis in HIV/Hepatitis C Virus-Coinfected Patients: A Sex-Based Analysis Using Transient Elastography at Enrollment in the HEPAVIH ANRS CO13 Cohort.
  Clinical Infectious Diseases, 2014
  Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP; HEPAVIH (ANRS CO13) Study Group.
  
  
• Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey).
  Sexually Transmitted Infections, 2014
  Marcellin F, Lorente N, Demoulin B, Carrieri MP, Suzan-Monti M, Roux P, Lert F, Sagaon-Teyssier L, Dray-Spira R, Spire B; and the ANRS VESPA2 Study Group.
  
  
• Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).
  Compr Psychiatry., 2015
  Michel L, Lions C, Maradan G, Mora M, Marcellin F, Morel A, Spire B, Roux P, Carrieri PM; Methaville Study Group.
  
  
• Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
  Expert Rev Gastroenterol Hepatol., 2015
  Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP; ANRS-VESPA2 Study Group.
  
  
• Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey).
  Sexually Transmitted Infections, 2015
  Marcellin F, Lorente N, Demoulin B, Carrieri MP, Suzan-Monti M, Roux P, Lert F, Sagaon-Teyssier L, Dray-Spira R, Spire B; ANRS VESPA2 Study Group.
  
  
• Risk factors for HCV reinfection or transmission in HIV-HCV co-infected MSM (ANRS VESPA2 French national survey)
  JAIDS, 2015
  Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B & the ANRS-VESPA2 Study Group.
  
  
• Cannabinoids and the immune system: no significant effect of cannabis use on CD4 T-cell populations in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH)
  Drug and Alcohol Review, 2015
  Marcellin F, Lions C, Rosenthal E, Roux P, Sogni P, Wittkop L, Protopopescu C, Spire B, Salmon-Céron D, Dabis F, Carrieri MP & the HEPAVIH ANRS CO13 Study Group